Skip to main content

Gregory Sullivan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Gregory Sullivan

Gregory Sullivan was last confirmed as Board Member at Carvana Co. (CVNA) in a filing dated March 25, 2025. Tonix Pharmaceuticals Holding Corp. reported in an 8-K filed July 21, 2026 that Gregory Sullivan retired as Chief Medical Officer, effective August 20, 2026. The proxy statement of Tonix Pharmaceuticals Holding Corp. reports total compensation of $1,216,542 for Gregory Sullivan in fiscal 2025, including a base salary of $519,168. Disclosed compensation is on record for 8 fiscal years.

“On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the “Company”) that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.”
Tonix Pharmaceuticals Holding Corp. Form 8-K, filed July 21, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Board Member

Since 2017-01-01, last confirmed 2025-03-25

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Tonix Pharmaceuticals Holding Corp. (TNXP) $519,168 $1,216,542
2024 Tonix Pharmaceuticals Holding Corp. (TNXP) $499,200 $922,444
2023 Tonix Pharmaceuticals Holding Corp. (TNXP) $480,000 $951,998
2022 Tonix Pharmaceuticals Holding Corp. (TNXP) $461,120 $1,478,661
2021 Tonix Pharmaceuticals Holding Corp. (TNXP) $440,000 $2,247,785
2020 Tonix Pharmaceuticals Holding Corp. (TNXP) $420,000 $1,382,420
2019 Tonix Pharmaceuticals Holding Corp. (TNXP) $400,000 $652,393
2018 Tonix Pharmaceuticals Holding Corp. (TNXP) $335,000 $721,855

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.